Reports on asthma therapy findings from University of Montreal provide new insights

Fresh data on asthma are presented in the report 'Low-dose fluticasone propionate with and without salmeterol in steroid-naive patients with mild, uncontrolled asthma.' According to recent research published in the journal Respiratory Medicine, "The role of combination ICS/LABA as initial controller therapy in mild, persistent asthma is uncertain. Therefore, the objective of this study was to compare the efficacy of initial controller therapy with fluticasone propionate (FP) 100 microg twice daily to the efficacy of fluticasone propionate/salmeterol xinafoate (FSC) 100/50 microg twice daily in patients with persistent asthma symptoms while using as-needed SABA alone."

...

Want to see the full article?

• Purchase this article for only $3.00